These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7731508

  • 1. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors.
    Stragliotto G, Fankhauser H.
    Neurosurgery; 1995 Feb; 36(2):285-92; discussion 292-3. PubMed ID: 7731508
    [Abstract] [Full Text] [Related]

  • 2. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [Abstract] [Full Text] [Related]

  • 3. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP, Brun A, Kahl SB, Koo MS, Persson BR, Salford LG.
    J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T, Nakagawa Y, Kitamura K, Matsumoto K, Hatanaka H.
    J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
    [Abstract] [Full Text] [Related]

  • 5. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 6. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):663-72. PubMed ID: 9112465
    [Abstract] [Full Text] [Related]

  • 7. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T, Nagahiro S, Kitamura K, Nakagawa Y, Hatanaka H, Haritz D, Grochulla F, Haselsberger K, Gabel D.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):120-30. PubMed ID: 11516861
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K, Miyatake S, Kajimoto Y, Kawabata S, Doi A, Yoshida T, Asano T, Kirihata M, Ono K, Kuroiwa T.
    J Neurooncol; 2006 Jul 01; 78(3):227-32. PubMed ID: 16557351
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G, Kawabata S, Nonoguchi N, Hiramatsu R, Toho T, Tanaka H, Masunaga SI, Hattori Y, Kirihata M, Ono K, Kuroiwa T, Miyatake SI.
    Radiat Oncol; 2017 Jan 23; 12(1):26. PubMed ID: 28114947
    [Abstract] [Full Text] [Related]

  • 10. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
    Verbakel WF, Sauerwein W, Hideghety K, Stecher-Rasmussen F.
    Int J Radiat Oncol Biol Phys; 2003 Mar 01; 55(3):743-56. PubMed ID: 12573762
    [Abstract] [Full Text] [Related]

  • 11. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.
    Ceberg CP, Brun A, Mir LM, Persson BR, Salford LG.
    Anticancer Drugs; 1994 Aug 01; 5(4):463-6. PubMed ID: 7949252
    [Abstract] [Full Text] [Related]

  • 12. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy.
    Ceberg CP, Persson A, Brun A, Huiskamp R, Fyhr AS, Persson BR, Salford LG.
    J Neurosurg; 1995 Jul 01; 83(1):79-85. PubMed ID: 7782854
    [Abstract] [Full Text] [Related]

  • 13. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration.
    Kraft SL, Gavin PR, Leathers CW, DeHaan CE, Bauer WF, Miller DL, Dorn RV, Griebenow ML.
    Cancer Res; 1994 Mar 01; 54(5):1259-63. PubMed ID: 8118814
    [Abstract] [Full Text] [Related]

  • 14. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
    Haritz D, Gabel D, Huiskamp R.
    Int J Radiat Oncol Biol Phys; 1994 Mar 30; 28(5):1175-81. PubMed ID: 8175403
    [Abstract] [Full Text] [Related]

  • 15. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T, Nagahiro S, Otersen B, Gabel D, Nakaichi M, Nakagawa Y.
    J Neurooncol; 2002 Sep 30; 59(2):135-42. PubMed ID: 12241106
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
    Yoshida F, Yamamoto T, Nakai K, Zaboronok A, Matsuda M, Akutsu H, Ishikawa E, Shirakawa M, Matsumura A.
    Appl Radiat Isot; 2014 Jun 30; 88():86-8. PubMed ID: 24731546
    [Abstract] [Full Text] [Related]

  • 17. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Anticancer Res; 2004 Jun 30; 24(5A):2975-83. PubMed ID: 15517904
    [Abstract] [Full Text] [Related]

  • 18. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
    Haselsberger K, Radner H, Pendl G.
    Neurosurgery; 1996 Aug 30; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
    [Abstract] [Full Text] [Related]

  • 19. Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.
    Otersen B, Haritz D, Grochulla F, Bergmann M, Sierralta W, Gabel D.
    J Neurooncol; 1997 May 30; 33(1-2):131-9. PubMed ID: 9151230
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE.
    J Nucl Med; 2005 Nov 30; 46(11):1858-65. PubMed ID: 16269600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.